StockMacro
Company, fund or insider

Help

Menu

National Healthcare

$190.77 +0.4% in 6 monthsMarket cap $3.0B

NHC on XASE, Health Care, National Healthcare Corp., job postings

Measures activity, not value. Not investment advice.

Shares fell 19% in a month after a 50% annual gain, while latest quarter revenue rose 6.6%.

  • GoodNet income rose 13% to $114.7M over the last 12 months

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

National Healthcare Corp provides long-term care facilities. Its principal business includes operating skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services and Home care and hospice services. The majority of revenue is derived from the Inpatient services segment.

Industry
Services-skilled nursing care facilities (Health Care)
Employees
15,278
Website
nhccare.com
Listed
NYSE American, US
Last results
6 Nov 2026
Next results
expected around 26 Feb 2027 (an estimate: a year ago it reported on 27 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $408.0M, net income $13.6M.
Quarter to 31 Dec 2021: revenue $283.4M, net income $15.8MQuarter to 31 Dec 2021: revenue $283.4M, net income $15.8MQuarter to 31 Mar 2022: revenue $279.0M, net income $15.3MQuarter to 31 Mar 2022: revenue $279.0M, net income $15.3MQuarter to 30 Jun 2022: revenue $271.4M, net income $3.2MQuarter to 30 Jun 2022: revenue $271.4M, net income $3.2MQuarter to 30 Sep 2022: revenue $270.8M, net income -$2.4MQuarter to 30 Sep 2022: revenue $270.8M, net income -$2.4MQuarter to 31 Dec 2022: revenue $264.6M, net income $6.4MQuarter to 31 Dec 2022: revenue $264.6M, net income $6.4MQuarter to 31 Mar 2023: revenue $269.6M, net income $11.7MQuarter to 31 Mar 2023: revenue $269.6M, net income $11.7MQuarter to 30 Jun 2023: revenue $282.6M, net income $16.3MQuarter to 30 Jun 2023: revenue $282.6M, net income $16.3MQuarter to 30 Sep 2023: revenue $288.5M, net income $10.4MQuarter to 30 Sep 2023: revenue $288.5M, net income $10.4MQuarter to 31 Dec 2023: revenue $300.9M, net income $28.4MQuarter to 31 Dec 2023: revenue $300.9M, net income $28.4MQuarter to 31 Mar 2024: revenue $297.2M, net income $26.2MQuarter to 31 Mar 2024: revenue $297.2M, net income $26.2MQuarter to 30 Jun 2024: revenue $300.7M, net income $26.8MQuarter to 30 Jun 2024: revenue $300.7M, net income $26.8MQuarter to 30 Sep 2024: revenue $340.2M, net income $42.8MQuarter to 30 Sep 2024: revenue $340.2M, net income $42.8MQuarter to 31 Dec 2024: revenue $369.4M, net income $6.1MQuarter to 31 Dec 2024: revenue $369.4M, net income $6.1MQuarter to 31 Mar 2025: revenue $373.7M, net income $32.2MQuarter to 31 Mar 2025: revenue $373.7M, net income $32.2MQuarter to 30 Jun 2025: revenue $374.9M, net income $23.7MQuarter to 30 Jun 2025: revenue $374.9M, net income $23.7MQuarter to 30 Sep 2025: revenue $382.7M, net income $39.2MQuarter to 30 Sep 2025: revenue $382.7M, net income $39.2MQuarter to 31 Dec 2025: revenue $386.5M, net income $24.8MQuarter to 31 Dec 2025: revenue $386.5M, net income $24.8MQuarter to 31 Mar 2026: revenue $381.8M, net income $35.9MQuarter to 31 Mar 2026: revenue $381.8M, net income $35.9MQuarter to 30 Jun 2026: revenue $408.0M, net income $40.3MQuarter to 30 Jun 2026: revenue $408.0M, net income $40.3MQuarter to 30 Sep 2026: revenue $408.0M, net income $13.6MQuarter to 30 Sep 2026: revenue $408.0M, net income $13.6M
31 Dec 2021RevenueNet incomeNet losstallest bar $408.0M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$408.0M$13.6M
30 Jun 2026$408.0M$40.3M
31 Mar 2026$381.8M$35.9M
31 Dec 2025$386.5M$24.8M
30 Sep 2025$382.7M$39.2M
30 Jun 2025$374.9M$23.7M
31 Mar 2025$373.7M$32.2M
31 Dec 2024$369.4M$6.1M
30 Sep 2024$340.2M$42.8M
30 Jun 2024$300.7M$26.8M
31 Mar 2024$297.2M$26.2M
31 Dec 2023$300.9M$28.4M
30 Sep 2023$288.5M$10.4M
30 Jun 2023$282.6M$16.3M
31 Mar 2023$269.6M$11.7M
31 Dec 2022$264.6M$6.4M
30 Sep 2022$270.8M-$2.4M
30 Jun 2022$271.4M$3.2M
31 Mar 2022$279.0M$15.3M
31 Dec 2021$283.4M$15.8M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $1.6B $1.5B
Revenue growthRevenue of the last 12 months compared with the 12 months before. +5.6% +9.8%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $114.7M $101.2M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $7.23 $6.47
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 63.5%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 9.8% 8.1% -9.1%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 7.2% 6.7% -7.6%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 10.5% -44.4%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – $146.9M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $66.8M $130.6M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $502.1M $73.1M
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $435.3M -$57.5M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.45 0.06
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $71.81
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 26.1 24.7
P/SPrice to sales: market cap divided by revenue of the last 12 months. 1.9 3.2
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 2.2 3.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 2.7 2.2
Dividend yieldDividends per share declared in the latest fiscal year divided by the share price. 1.3% 1.6%

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
National HealthcareNHC (this company) $3.0B26.11.9+5.6%7.2%
PACSPACS $6.9B25.01.2+11%4.9%
EnsignENSG $10.3B25.81.8+17%7.0%
TransMedicsTMDX $3.0B20.54.1+28%19.9%
Denali TherapeuticsDNLI $3.0Bloss–––
Acadia PharmaceuticalsACAD $3.0B8.22.5+15%30.1%

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+6.6%

$408.0M vs $382.7M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

+23%

$12.5M vs $10.2M (quarter ended 30 Jun 2026)

Insider buy/sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$5.2M

bought $0, sold $5.2M

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+12%

272 13F filers vs 242

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

67%

10.4M shares held by 13F filers (30 Sep 2026) of 15.7M outstanding (2 Nov 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

4.9%

770K shares sold short (30 Oct 2026) of 15.7M outstanding (2 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

4.5

770K shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+1.9%

755K shares sold short in the report before, 770K on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

64%

64% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 75%

News Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

26

26 articles in the last 7 days; its usual week has 4.5 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

5.8×

26 articles in the last 7 days; its usual week has 4.5.

Price $190.77 on 20 Nov 2026, +50% over 12 months (12-month range $127.36 to $247.94)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $9.1M in the last 12 months (the 12 months before: -$8.0M).
Revenue per quarter. Revenue $408.0M in the latest quarter, +6.6% on a year earlier.
Capital spending per quarter. Capital spending $12.5M in the latest quarter, +23% on a year earlier.
Institutional holders (13F filers). 272 13F filers reported holding it in the latest 13F quarter, +39% on a year earlier.
Federal obligations. Federal obligations: $0 published in the last 12 months, -100% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
1 Jul 20268-K and other filingsCompleted an acquisition or asset sale
1 Jul 20268-K and other filingsA major agreement ended
2 Jun 2026Sharp changeShort interest spike: short interest spike, 636K vs usual 309K (2026-05-15); 2.9x the same period a year earlier
27 May 20268-K and other filingsA major agreement ended
12 May 2026Sharp changeShort interest spike: short interest spike, 690K vs usual 299K (2026-04-30); 2.7x the same period a year earlier
28 Apr 2026Sharp changeShort interest spike: short interest spike, 765K vs usual 292K (2026-04-15); 3.0x the same period a year earlier
21 Apr 20268-K and other filingsA major agreement ended
14 Apr 2026Sharp changeShort interest spike: short interest spike, 713K vs usual 292K (2026-03-31); 2.4x the same period a year earlier
31 Mar 2026Sharp changeShort interest spike: short interest spike, 581K vs usual 292K (2026-03-13); 1.8x the same period a year earlier
17 Feb 20268-K and other filingsDirector or officer change
17 Feb 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
12 Nov 20258-K and other filingsDirector or officer change
26 Sep 20258-K and other filingsDirector or officer change
26 Sep 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
8 Apr 20258-K and other filingsChanged its auditor
13 Nov 20248-K and other filingsDirector or officer change
13 Nov 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
6 Aug 20248-K and other filingsCompleted an acquisition or asset sale
11 Jul 20248-K and other filingsDirector or officer change
11 Jul 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
21 May 2024Sharp changeMany funds opening a new position: many funds opening a new position, 29 vs usual 11.50 (2024-03-31); 1.4x the same period a year earlier
20 Feb 2024Sharp changeMany funds opening a new position: many funds opening a new position, 32 vs usual 10.50 (2023-12-31); 2.9x the same period a year earlier
16 Jan 2024Sharp changeShort interest spike: short interest spike, 779K vs usual 364K (2023-12-29); 2.2x the same period a year earlier
26 May 20238-K and other filingsDirector or officer change
12 May 20238-K and other filingsDirector or officer change
12 May 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
28 Mar 2023Sharp changeShort interest spike: short interest spike, 517K vs usual 205K (2023-03-15); 3.5x the same period a year earlier
7 Sep 20228-K and other filingsA major agreement ended
6 Apr 2022Sharp changeFirst federal award: first federal award: NHC HEALTHCARE-CHARLESTON, LLC: new Department of Veterans Affairs contract 36C24722K0082 ($1,056,853)
22 Feb 2022Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 13.6M vs usual 6.3M (2021-12-31); 3.3x the same period a year earlier
28 Jan 20228-K and other filingsDirector or officer change
28 Jan 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Dec 2022: -$819K published
Month from 1 Feb 2023: $125K published
Month from 1 May 2023: $135K published
Month from 1 Jul 2023: $129K published
Month from 1 Aug 2023: $19K published
Month from 1 Sep 2023: $131K published
Month from 1 Dec 2023: -$1.3M published
Month from 1 Aug 2024: -$698K published
Month from 1 Sep 2024: -$260K published
Month from 1 Dec 2024: -$3.2M published
Month from 1 Jan 2025: -$2.8M published
Month from 1 Nov 2025: -$1.9M published
Month from 1 Dec 2025: -$342K published
Month from 1 May 2026: -$1.8M published
Month from 1 Jun 2026: -$1.3M published
Month from 1 Aug 2026: -$757K published
Month from 1 Sep 2026: -$4.8M published
Revenue per quarter
Quarter ended 31 Dec 2021: $283.4M, +9.1% on a year earlier; public on 19 Feb 2022
Quarter ended 31 Mar 2022: $279.0M, +11% on a year earlier; public on 6 May 2022
Quarter ended 30 Jun 2022: $271.4M, +3.1% on a year earlier; public on 5 Aug 2022
Quarter ended 30 Sep 2022: $270.8M, -2.1% on a year earlier; public on 4 Nov 2022
Quarter ended 31 Dec 2022: $264.6M, -6.7% on a year earlier; public on 18 Feb 2023
Quarter ended 31 Mar 2023: $269.6M, -3.4% on a year earlier; public on 5 May 2023
Quarter ended 30 Jun 2023: $282.6M, +4.1% on a year earlier; public on 4 Aug 2023
Quarter ended 30 Sep 2023: $288.5M, +6.5% on a year earlier; public on 3 Nov 2023
Quarter ended 31 Dec 2023: $300.9M, +14% on a year earlier; public on 17 Feb 2024
Quarter ended 31 Mar 2024: $297.2M, +10% on a year earlier; public on 10 May 2024
Quarter ended 30 Jun 2024: $300.7M, +6.4% on a year earlier; public on 9 Aug 2024
Quarter ended 30 Sep 2024: $340.2M, +18% on a year earlier; public on 8 Nov 2024
Quarter ended 31 Dec 2024: $369.4M, +23% on a year earlier; public on 1 Mar 2025
Quarter ended 31 Mar 2025: $373.7M, +26% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $374.9M, +25% on a year earlier; public on 8 Aug 2025
Quarter ended 30 Sep 2025: $382.7M, +12% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Dec 2025: $386.5M, +4.6% on a year earlier; public on 27 Feb 2026
Quarter ended 31 Mar 2026: $381.8M, +2.2% on a year earlier; public on 8 May 2026
Quarter ended 30 Jun 2026: $408.0M, +8.8% on a year earlier; public on 7 Aug 2026
Quarter ended 30 Sep 2026: $408.0M, +6.6% on a year earlier; public on 6 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $13.6M, +228% on a year earlier; public on 19 Feb 2022
Quarter ended 31 Mar 2022: $9.0M, +107% on a year earlier; public on 6 May 2022
Quarter ended 30 Jun 2022: $8.1M, -8.5% on a year earlier; public on 5 Aug 2022
Quarter ended 30 Sep 2022: $7.5M, -40% on a year earlier; public on 4 Nov 2022
Quarter ended 31 Dec 2022: $5.6M, -59% on a year earlier; public on 18 Feb 2023
Quarter ended 31 Mar 2023: $6.6M, -26% on a year earlier; public on 5 May 2023
Quarter ended 30 Jun 2023: $6.1M, -24% on a year earlier; public on 4 Aug 2023
Quarter ended 30 Sep 2023: $6.5M, -14% on a year earlier; public on 3 Nov 2023
Quarter ended 31 Dec 2023: $8.6M, +53% on a year earlier; public on 17 Feb 2024
Quarter ended 31 Mar 2024: $6.0M, -10% on a year earlier; public on 10 May 2024
Quarter ended 30 Jun 2024: $7.8M, +27% on a year earlier; public on 9 Aug 2024
Quarter ended 30 Sep 2024: $5.7M, -13% on a year earlier; public on 8 Nov 2024
Quarter ended 31 Dec 2024: $8.2M, -5.2% on a year earlier; public on 1 Mar 2025
Quarter ended 31 Mar 2025: $6.1M, +3.1% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $10.2M, +30% on a year earlier; public on 8 Aug 2025
Quarter ended 30 Sep 2025: $9.7M, +72% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Dec 2025: $10.4M, +27% on a year earlier; public on 27 Feb 2026
Quarter ended 31 Mar 2026: $9.6M, +57% on a year earlier; public on 8 May 2026
Quarter ended 30 Jun 2026: $12.5M, +23% on a year earlier; public on 7 Aug 2026
Institutional holders (13F filers)
31 Dec 2021 report: 120; public on 14 Feb 2022
31 Mar 2022 report: 117; public on 16 May 2022
30 Jun 2022 report: 115; public on 15 Aug 2022
30 Sep 2022 report: 117; public on 14 Nov 2022
31 Dec 2022 report: 108; public on 14 Feb 2023
31 Mar 2023 report: 128; public on 15 May 2023
30 Jun 2023 report: 121; public on 14 Aug 2023
30 Sep 2023 report: 119; public on 14 Nov 2023
31 Dec 2023 report: 150; public on 14 Feb 2024
31 Mar 2024 report: 163; public on 15 May 2024
30 Jun 2024 report: 166; public on 14 Aug 2024
30 Sep 2024 report: 188; public on 14 Nov 2024
31 Dec 2024 report: 182; public on 14 Feb 2025
31 Mar 2025 report: 174; public on 15 May 2025
30 Jun 2025 report: 180; public on 14 Aug 2025
30 Sep 2025 report: 195; public on 14 Nov 2025
31 Dec 2025 report: 211; public on 17 Feb 2026
31 Mar 2026 report: 233; public on 15 May 2026
30 Jun 2026 report: 242; public on 14 Aug 2026
30 Sep 2026 report: 272; public on 16 Nov 2026
Federal obligations
Month from 1 Nov 2021: $331K published
Month from 1 Dec 2021: $525K published
Month from 1 Jan 2022: $417K published
Month from 1 Feb 2022: $192K published
Month from 1 Apr 2022: $2.2M published
Month from 1 Jul 2022: $956K published
Month from 1 Aug 2022: $1.5M published
Month from 1 Oct 2022: $358K published
Month from 1 Jan 2023: $1.3M published
Month from 1 Feb 2023: $152K published
Month from 1 Apr 2023: $90K published
Month from 1 Jul 2023: $174K published
Month from 1 Oct 2023: $598K published
Month from 1 Dec 2023: $218K published
Month from 1 Apr 2024: $1.1M published
Month from 1 May 2024: $109K published
Month from 1 Jun 2024: $466K published
Month from 1 Jul 2024: $854K published
Month from 1 Oct 2024: $2.2M published
Month from 1 Jan 2025: $435K published
Month from 1 Apr 2025: $618K published
Month from 1 Jun 2025: -$369K published
Month from 1 Aug 2025: -$296K published
Month from 1 Sep 2025: $162K published
Month from 1 Oct 2025: $14K published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is 13F holders (funds reporting the stock) at 272 (30 Sep 2026), 1.5× its normal reading; higher than 100% of its own history.
  • Short interest spike: had 636K shares sold short in the 15 May 2026 report, 2.9× the same report last year Public on 28 May 2026.
  • Insider net buying (open market): Insiders sold a net $9.1M in the last 12 months (the 12 months before: -$8.0M).
  • Revenue per quarter: Revenue $408.0M in the latest quarter, +6.6% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 67 insider trades

Last 90 days: 5 sales, $5.2M; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
23 Sep 2026Vicki L DodsonSr.VP Patient SrvcsSell4,834$225.00$1.1MForm 4
14 Sep 2026Josh A McCrearySenior VP & General CounselSell2,719$224.23$610KForm 4
14 Sep 2026Brian F KiddSVP, CFOSell6,813$225.70$1.5MForm 4
2 Sep 2026Ben Anderson Flatt SrSenior VP & CIOSell7,000$227.57$1.6MForm 4
28 Aug 2026David R. GiffordDirectorSell1,779$225.42$401KForm 4
20 Aug 2026Stephen Fowler FlattCEOSell1,500$237.08$356KForm 4
23 Jun 2026Emil E HassanDirectorSell5,937$200.00$1.2MForm 4
18 Jun 2026Emil E HassanDirectorSell1,563$199.98$313KForm 4

272 institutions reported shares at the end of Q3 2026, 67% of the shares outstanding; 42 opened a position, 18 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.2.0M12.8%$438.8M+23K+1.2%
Morgan Stanley Institutional Investment Advisors LLC971K6.20%$213.1M-58K-5.6%
Dimensional Fund Advisors LP931K5.95%$204.4M+1,623+0.2%
Vanguard Portfolio Management LLC820K5.23%$179.9M+10K+1.3%
First Trust Advisors LP659K4.21%$144.7M-71K-9.8%
Vanguard Capital Management LLC555K3.54%$121.7M+2,428+0.4%
State Street Corp531K3.39%$117.0M+4,630+0.9%
Geode Capital Management, LLC375K2.40%$82.4M-5,738-1.5%
Renaissance Technologies LLC263K1.68%$57.8M-37K-12%
Invesco Ltd.228K1.46%$50.1M+53K+30%

Federal contracts

All 3 federal contracts

No new award in 12 months; the latest was signed 1 Oct 2024. New awards only; later changes to an award are not listed.

SignedAgencyAmountWhat forSource
1 Oct 2024Department of Veterans Affairs$1.5MEXERCISE ORDERING PERIOD TWO(2) - COMMUNITY NURSING HOME (SKILLED NURSING) SERVICESUSAspending
31 Dec 2022Department of Veterans Affairs$1.2MCONTRACT NURSING SERVICE FUNDING ACTION ONLYUSAspending
31 Mar 2022Department of Veterans Affairs$1.1MEXPRESS REPORT: CNH SERVICEUSAspending

Company events

All 32 company events

In 12 months: 4 major agreements, 3 agreements ended, 1 director or officer change, 1 completed deal. Results releases and routine reports are left out.

FiledWhat happenedSource
1 Jul 2026Signed a major agreement; A major agreement ended; Completed an acquisition or asset saleSame filing: took on new debt8-K
27 May 2026Signed a major agreement; A major agreement endedSame filing: took on new debt8-K
15 May 2026Signed a major agreement8-K
21 Apr 2026Signed a major agreement; A major agreement ended8-K
17 Feb 2026Director or officer change8-K
12 Nov 2025Director or officer change8-K
26 Sep 2025Director or officer change8-K
8 Apr 2025Changed its auditor8-K

Reported lobbying spend: $10K in Q1 2018, $20K in Q4 2017. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
28 Feb 2018EndedThe Ingram Group LLCfor National Healthcare CorporationIssues related to Medicaid funding levels.Medicare/MedicaidFiling
1 Jun 2017NewThe Ingram Group LLCfor National Healthcare CorporationH.R.1628, American Health Care Act of 2017; issues related to Medicaid funding levels.Medicare/MedicaidFiling
31 Dec 2008EndedBaker Donelson Bearman Caldwell & Berkowitzfor National Healthcare CorporationLong term care reformHealth issuesFiling
28 Sep 2007NewBaker Donelson Bearman Caldwell & Berkowitzfor National Healthcare CorporationLong term care liability reformHealth issuesFiling

The 5 newest of 258 articles that name the company.

Timeline

Timeline

Changes and notable records, by the date each became public

  1. 1 Jul 2026Filings record

    Completed an acquisition or asset sale

  2. 1 Jul 2026Filings record

    A major agreement ended

  3. 3 Jun 2026Insiders record

    Piercey Lisa (director) bought 949 shares of NHC ($174,863) (dated 2 Jun 2026)

  4. 28 May 2026Short interest and volume change

    had 636K shares sold short in the 15 May 2026 report, 2.9× the same report last year.

    Same report last year: 221K; its normal report is 309K.

    See the evidence
    This period
    636K (the 15 May 2026 report)
    Normal report (median of 24 earlier)
    309K
    Typical spread (median absolute deviation)
    55K
    How far from its usual level
    +4.0
    Same report last year
    221K
    History used
    3,059 days
    2025-05-15: 221K2025-05-30: 197K2025-06-13: 260K2025-06-30: 287K2025-07-15: 249K2025-07-31: 256K2025-08-15: 254K2025-08-29: 253K2025-09-15: 260K2025-09-30: 330K2025-10-15: 291K2025-10-31: 294K2025-11-14: 304K2025-11-28: 313K2025-12-15: 326K2025-12-31: 417K2026-01-15: 338K2026-01-30: 378K2026-02-13: 418K2026-02-27: 478K2026-03-13: 581K2026-03-31: 713K2026-04-15: 765K2026-04-30: 690K2026-05-15: 636K
    the 15 May 2026 report24 earlier reportsnormal: 309K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  5. 27 May 2026Filings record

    A major agreement ended

  6. 12 May 2026Short interest and volume change

    had 690K shares sold short in the 30 Apr 2026 report, 2.7× the same report last year.

    Same report last year: 260K; its normal report is 299K.

    See the evidence
    This period
    690K (the 30 Apr 2026 report)
    Normal report (median of 24 earlier)
    299K
    Typical spread (median absolute deviation)
    44K
    How far from its usual level
    +6.0
    Same report last year
    260K
    History used
    3,044 days
    2025-04-30: 260K2025-05-15: 221K2025-05-30: 197K2025-06-13: 260K2025-06-30: 287K2025-07-15: 249K2025-07-31: 256K2025-08-15: 254K2025-08-29: 253K2025-09-15: 260K2025-09-30: 330K2025-10-15: 291K2025-10-31: 294K2025-11-14: 304K2025-11-28: 313K2025-12-15: 326K2025-12-31: 417K2026-01-15: 338K2026-01-30: 378K2026-02-13: 418K2026-02-27: 478K2026-03-13: 581K2026-03-31: 713K2026-04-15: 765K2026-04-30: 690K
    the 30 Apr 2026 report24 earlier reportsnormal: 299K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  7. 25 Apr 2026Short interest and volume change

    had 765K shares sold short in the 15 Apr 2026 report, 3.0× the same report last year.

    Same report last year: 256K; its normal report is 292K.

    See the evidence
    This period
    765K (the 15 Apr 2026 report)
    Normal report (median of 24 earlier)
    292K
    Typical spread (median absolute deviation)
    38K
    How far from its usual level
    +8.4
    Same report last year
    256K
    History used
    3,029 days
    2025-04-15: 256K2025-04-30: 260K2025-05-15: 221K2025-05-30: 197K2025-06-13: 260K2025-06-30: 287K2025-07-15: 249K2025-07-31: 256K2025-08-15: 254K2025-08-29: 253K2025-09-15: 260K2025-09-30: 330K2025-10-15: 291K2025-10-31: 294K2025-11-14: 304K2025-11-28: 313K2025-12-15: 326K2025-12-31: 417K2026-01-15: 338K2026-01-30: 378K2026-02-13: 418K2026-02-27: 478K2026-03-13: 581K2026-03-31: 713K2026-04-15: 765K
    the 15 Apr 2026 report24 earlier reportsnormal: 292K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  8. 21 Apr 2026Filings record

    A major agreement ended

  9. 11 Apr 2026Short interest and volume change

    had 713K shares sold short in the 31 Mar 2026 report, 2.4× the same report last year.

    Same report last year: 300K; its normal report is 292K.

    See the evidence
    This period
    713K (the 31 Mar 2026 report)
    Normal report (median of 24 earlier)
    292K
    Typical spread (median absolute deviation)
    37K
    How far from its usual level
    +7.6
    Same report last year
    300K
    History used
    3,014 days
    2025-03-31: 300K2025-04-15: 256K2025-04-30: 260K2025-05-15: 221K2025-05-30: 197K2025-06-13: 260K2025-06-30: 287K2025-07-15: 249K2025-07-31: 256K2025-08-15: 254K2025-08-29: 253K2025-09-15: 260K2025-09-30: 330K2025-10-15: 291K2025-10-31: 294K2025-11-14: 304K2025-11-28: 313K2025-12-15: 326K2025-12-31: 417K2026-01-15: 338K2026-01-30: 378K2026-02-13: 418K2026-02-27: 478K2026-03-13: 581K2026-03-31: 713K
    the 31 Mar 2026 report24 earlier reportsnormal: 292K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  10. 25 Mar 2026Short interest and volume change

    had 581K shares sold short in the 13 Mar 2026 report, 1.8× the same report last year.

    Same report last year: 320K; its normal report is 292K.

    See the evidence
    This period
    581K (the 13 Mar 2026 report)
    Normal report (median of 24 earlier)
    292K
    Typical spread (median absolute deviation)
    36K
    How far from its usual level
    +5.4
    Same report last year
    320K
    History used
    2,996 days
    2025-03-14: 320K2025-03-31: 300K2025-04-15: 256K2025-04-30: 260K2025-05-15: 221K2025-05-30: 197K2025-06-13: 260K2025-06-30: 287K2025-07-15: 249K2025-07-31: 256K2025-08-15: 254K2025-08-29: 253K2025-09-15: 260K2025-09-30: 330K2025-10-15: 291K2025-10-31: 294K2025-11-14: 304K2025-11-28: 313K2025-12-15: 326K2025-12-31: 417K2026-01-15: 338K2026-01-30: 378K2026-02-13: 418K2026-02-27: 478K2026-03-13: 581K
    the 13 Mar 2026 report24 earlier reportsnormal: 292K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  11. 17 Feb 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  12. 17 Feb 2026Filings record

    Director or officer change

  13. 12 Nov 2025Filings record

    Director or officer change

  14. 26 Sep 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  15. 26 Sep 2025Filings record

    Director or officer change

  16. 8 Apr 2025Filings record

    Changed its auditor

  17. 13 Nov 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  18. 13 Nov 2024Filings record

    Director or officer change

  19. 7 Oct 2024Government contracts record

    NHC HEALTHCARE/JOPLIN, LLC: new Department of Veterans Affairs contract 36C25625N0049 ($1.8M) (dated 1 Oct 2024)

  20. 6 Aug 2024Filings record

    Completed an acquisition or asset sale

  21. 11 Jul 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  22. 11 Jul 2024Filings record

    Director or officer change

  23. 15 May 2024Institutional holdings change

    saw 29 13F filers open a new position in the quarter ended 31 Mar 2024, 1.4× the same quarter last year.

    Same quarter last year: 20; its normal quarter is 11.5.

    See the evidence
    This period
    29 (the quarter ended 31 Mar 2024)
    Normal quarter (median of 8 earlier)
    11.5
    Typical spread (median absolute deviation)
    3
    How far from its usual level
    +3.9
    Same quarter last year
    20
    History used
    3,835 days
    2022-03-31: 62022-06-30: 122022-09-30: 122022-12-31: 112023-03-31: 202023-06-30: 92023-09-30: 82023-12-31: 322024-03-31: 29
    the quarter ended 31 Mar 20248 earlier quartersnormal: 11.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  24. 14 Feb 2024Institutional holdings change

    saw 32 13F filers open a new position in the quarter ended 31 Dec 2023, 2.9× the same quarter last year.

    Same quarter last year: 11; its normal quarter is 10.5.

    See the evidence
    This period
    32 (the quarter ended 31 Dec 2023)
    Normal quarter (median of 8 earlier)
    10.5
    Typical spread (median absolute deviation)
    1.5
    How far from its usual level
    +7.2
    Same quarter last year
    11
    History used
    3,744 days
    2021-12-31: 102022-03-31: 62022-06-30: 122022-09-30: 122022-12-31: 112023-03-31: 202023-06-30: 92023-09-30: 82023-12-31: 32
    the quarter ended 31 Dec 20238 earlier quartersnormal: 10.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  25. 11 Jan 2024Short interest and volume change

    had 779K shares sold short in the 29 Dec 2023 report, 2.2× the same report last year.

    Same report last year: 353K; its normal report is 364K.

    See the evidence
    This period
    779K (the 29 Dec 2023 report)
    Normal report (median of 24 earlier)
    364K
    Typical spread (median absolute deviation)
    53K
    How far from its usual level
    +5.3
    Same report last year
    353K
    History used
    2,191 days
    2022-12-30: 353K2023-01-13: 374K2023-01-31: 387K2023-02-15: 390K2023-02-28: 427K2023-03-15: 517K2023-03-31: 424K2023-04-14: 384K2023-04-28: 428K2023-05-15: 464K2023-05-31: 418K2023-06-15: 416K2023-06-30: 387K2023-07-14: 350K2023-07-31: 352K2023-08-15: 352K2023-08-31: 324K2023-09-15: 309K2023-09-29: 300K2023-10-13: 293K2023-10-31: 285K2023-11-15: 290K2023-11-30: 239K2023-12-15: 332K2023-12-29: 779K
    the 29 Dec 2023 report24 earlier reportsnormal: 364K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  26. 15 Sep 2023Insiders record

    ADAMS ROBERT G (director) bought 2,000 shares of NHC ($133,920) [amended] (dated 14 Sep 2023)

  27. 8 Sep 2023Insiders record

    ADAMS ROBERT G (director) bought 2,000 shares of NHC ($130,800) (dated 7 Sep 2023)

  28. 11 Aug 2023Insiders record

    ADAMS W ANDREW (director) bought 1,861 shares of NHC ($125,003) (dated 10 Aug 2023)

  29. 4 Jul 2023Insiders record

    LAROCHE RICHARD F JR (director) bought 2,100 shares of NHC ($128,940) (dated 3 Jul 2023)

  30. 26 May 2023Filings record

    Director or officer change

  31. 18 May 2023Insiders record

    BURGESS ERNEST G III (director) bought 2,300 shares of NHC ($135,355) (dated 17 May 2023)

  32. 12 May 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  33. 12 May 2023Filings record

    Director or officer change

  34. 25 Mar 2023Short interest and volume change

    had 517K shares sold short in the 15 Mar 2023 report, 3.5× the same report last year.

    Same report last year: 147K; its normal report is 205K.

    See the evidence
    This period
    517K (the 15 Mar 2023 report)
    Normal report (median of 24 earlier)
    205K
    Typical spread (median absolute deviation)
    35K
    How far from its usual level
    +6.1
    Same report last year
    147K
    History used
    1,902 days
    2022-03-15: 147K2022-03-31: 204K2022-04-14: 178K2022-04-29: 192K2022-05-13: 189K2022-05-31: 170K2022-06-15: 203K2022-06-30: 227K2022-07-15: 214K2022-07-29: 201K2022-08-15: 183K2022-08-31: 160K2022-09-15: 171K2022-09-30: 182K2022-10-14: 207K2022-10-31: 275K2022-11-15: 300K2022-11-30: 273K2022-12-15: 294K2022-12-30: 353K2023-01-13: 374K2023-01-31: 387K2023-02-15: 390K2023-02-28: 427K2023-03-15: 517K
    the 15 Mar 2023 report24 earlier reportsnormal: 205K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  35. 28 Feb 2023Insiders record

    ABERNATHY JAMES PAUL (director) bought 2,176 shares of NHC ($125,011) (dated 27 Feb 2023)

  36. 6 Jan 2023Government contracts record

    NHC HEALTHCARE/JOPLIN, LLC: new Department of Veterans Affairs contract 36C25623N0038 ($1.2M) (dated 31 Dec 2022)

  37. 7 Sep 2022Filings record

    A major agreement ended

  38. 6 Apr 2022Government contracts change

    won its first federal award in our data, a $1.1M Department of Veterans Affairs contract.

    See the evidence (1 source record)
    Source coverage starts
    7 Oct 2007
    Earlier events of other kinds
    0

    "First" means first in our data: it fires only when the source's history began at least 365 days earlier.

  39. 6 Apr 2022Government contracts record

    NHC HEALTHCARE-CHARLESTON, LLC: new Department of Veterans Affairs contract 36C24722K0082 ($1.1M) (dated 31 Mar 2022)

  40. 22 Feb 2022Financials change

    spent $13.6M on capital projects in the quarter ended 31 Dec 2021, 3.3× the same quarter last year.

    Same quarter last year: $4.2M; its normal quarter is $6.3M.

    See the evidence
    This period
    $13.6M (the quarter ended 31 Dec 2021)
    Normal quarter (median of 8 earlier)
    $6.3M
    Typical spread (median absolute deviation)
    $1.5M
    How far from its usual level
    +3.3
    Same quarter last year
    $4.2M
    History used
    4,110 days
    2019-12-31: $6.7M2020-03-31: $6.6M2020-06-30: $5.9M2020-09-30: $5.2M2020-12-31: $4.2M2021-03-31: $4.3M2021-06-30: $8.8M2021-09-30: $12.6M2021-12-31: $13.6M
    the quarter ended 31 Dec 20218 earlier quartersnormal: $6.3M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

Showing the newest 40 of 57 entries; narrow the window or the kind of data to see older ones.

Not listed: 206 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001047335
Ticker
NHC
Domain
nhccare.com
Employer name
National Healthcare Corporation (1 unverified)
Fein
62-1294263 (1 unverified)
Hq location
TN|MURFREESBORO|37130 (1 unverified)
Lobbying client
national healthcare
Name
AdamsPlace, LLC, Buckley HealthCare Center, LLC, Caris HealthCare, L.P, City Center, L.P and 136 more
Uei
D6JZGCAMRH85, MCP4B7GGKJ11, NDM3SMS1M443, VUDHW89EGSS9
Wikipedia
National Healthcare
  • DOL H-1B labor condition applications and PERM certifications12 data points3 Feb 2025 to 2 Feb 2026
  • Federal lobbying disclosures (LDA)4 records, 27 data points28 Sep 2007 to 31 Mar 2018
  • SEC Form 13F institutional holdings481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)170 records12 Feb 2016 to 6 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)944 data points31 Dec 2008 to 2 Nov 2026
  • SEC Form 4 insider transactions67 records, 232 data points9 May 2016 to 23 Sep 2026
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards3 records, 468 data points1 Oct 2007 to 20 Oct 2025
  • Wikipedia pageviews11 data points11 Nov 2026 to 21 Nov 2026